tazarotene has been researched along with benzoyl peroxide in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Draelos, ZD; Tanghetti, EA | 1 |
| Liao, DC | 1 |
| Shalita, A | 1 |
| Abramovits, W; Loven, K; Shalita, A; Solomon, B; Tanghetti, E | 1 |
| Bikowski, J; Callender, VD; Del Rosso, JQ; Draelos, ZD; Tanghetti, E | 1 |
| Dhawan, SS; Gwazdauskas, J | 1 |
| Dressler, C; Nast, A; Rosumeck, S | 1 |
2 review(s) available for tazarotene and benzoyl peroxide
| Article | Year |
|---|---|
Management of acne.
Topics: Acne Vulgaris; Adapalene; Administration, Oral; Administration, Topical; Algorithms; Anti-Bacterial Agents; Benzoyl Peroxide; Contraceptives, Oral; Controlled Clinical Trials as Topic; Cost-Benefit Analysis; Decision Trees; Dermatologic Agents; Dicarboxylic Acids; Humans; Isotretinoin; Macrolides; Naphthalenes; Nicotinic Acids; Salicylates; Tretinoin; United States | 2003 |
How Much Do We Know about Maintaining Treatment Response after Successful Acne Therapy? Systematic Review on the Efficacy and Safety of Acne Maintenance Therapy.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Benzoyl Peroxide; Dermatologic Agents; Gels; Humans; Isotretinoin; Nicotinic Acids; Treatment Outcome | 2016 |
4 trial(s) available for tazarotene and benzoyl peroxide
| Article | Year |
|---|---|
Optimizing the use of tazarotene for the treatment of facial acne vulgaris through combination therapy.
Topics: Acne Vulgaris; Administration, Cutaneous; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; California; Child; Clindamycin; Dermatologic Agents; Drug Therapy, Combination; Erythromycin; Facial Dermatoses; Female; Gels; Humans; Male; Nicotinic Acids; North Carolina; Severity of Illness Index; Treatment Outcome | 2002 |
Topical tazarotene: The BEST (balancing efficacy, speed, and tolerability) in acne trial.
Topics: Acne Vulgaris; Administration, Cutaneous; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Drug Administration Schedule; Drug Therapy, Combination; Face; Female; Gels; Humans; Male; Nicotinic Acids; Retinoids; Risk Factors; Time Factors; Treatment Outcome; United States | 2004 |
Tazarotene versus tazarotene plus clindamycin/benzoyl peroxide in the treatment of acne vulgaris: a multicenter, double-blind, randomized parallel-group trial.
Topics: Acne Vulgaris; Administration, Cutaneous; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Double-Blind Method; Drug Therapy, Combination; Emollients; Female; Humans; Male; Nicotinic Acids; Severity of Illness Index; Treatment Outcome; United States | 2006 |
Clindamycin phosphate 1.2%-benzoyl peroxide (5% or 2.5%) plus tazarotene cream 0.1% for the treatment of acne.
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Benzoyl Peroxide; Chi-Square Distribution; Child; Clindamycin; Dermatologic Agents; Drug Combinations; Face; Female; Gels; Humans; Male; Nicotinic Acids; Ointments; Quality of Life; Severity of Illness Index; Single-Blind Method; Statistics, Nonparametric; Surveys and Questionnaires; Treatment Outcome | 2013 |
1 other study(ies) available for tazarotene and benzoyl peroxide
| Article | Year |
|---|---|
Combining clindamycin 1%-benzoyl peroxide 5% gel with multiple therapeutic options.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Drug Combinations; Female; Gels; Humans; Keratolytic Agents; Male; Minocycline; Naphthalenes; Nicotinic Acids; Retinoids; Treatment Outcome; Tretinoin | 2006 |